Recursion Pharmaceuticals Inc Clas (RXRX)
Stock-Based Compensation
$90.72M
TTM · Period ending: · USD
RXRX Stock-Based Compensation
Latest reported$90.72Mperiod ending
Latest reported$90.72Mperiod ending
RXRX TTM Stock-Based Comp ($4.29M → $90.72M)
TTM stock-based compensation
High-resolution chart · PNG
RXRX stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 90,719,000 | |
| 97,380,000 | |
| 111,223,000 | |
| 118,244,000 | |
| 111,254,000 | |
| 101,619,000 | |
| 81,688,000 | |
| 66,990,000 | |
| 65,529,000 | |
| 60,816,000 | |
| 53,503,000 | |
| 45,112,000 | |
| 37,227,000 | |
| 31,091,000 | |
| 27,909,000 | |
| 24,555,000 | |
| 19,011,000 | |
| 18,653,000 | |
| 14,842,000 | |
| 11,689,000 | |
| 9,396,000 | |
| 4,848,000 | |
| 4,292,000 |